
RecombinantCCL19(MIP-3β)
CatalogNo.Size
50184P-22ug
50184P-1010ug
50184P-5050ug
50184P-100100ug
50184P-10001000ug
CCL19(alsoknownasMacrophageInflammatoryProtein-3beta,MIP-3β,andEBI1ligandchemokine,ELC)directschemotaxisofdendriticcellsandcertainB-andT-lymphocytes,butnotmonocytesorgranulocytes.ItisconstitutivelyexpressedinthymusandlymphnodesandbindsspecificallytotargetcellsexpressingthereceptorCCR7.Asahomeostaticchemokine,itsprimaryphysiologicalroleisthoughttobeinthenormalrecirculationandhomingoflymphocytes.However,CCL19canalsobeproinflammatoryandisimplicatedinpost-HIVinfectionresponses.
Source:RecombinanthumanCCL19producedinE.coli(accessionno.Q99731).
ProteinSequence:GTNDAEDCCLSVTQKPIPGYIVRNFHYLLIKDGCRVPAVVFTTLRGRQLCAPPDQPWVERIIQRLQRTSAKMKRRSS
MolecularMass:8.8kDabyMassSpec.
Purity:>97%bySDS-PAGE
Activity:EC50=30nMdeterminedbycalciumfluxwithrecombinanthumanCCR7.
EndotoxinLevel:<0.01EUper1ugofproteinbyLALmethod.
Form:Lyophilized.
CarrierProtein:None.
Reconstitution:Recommendedat100ug/mlinsteriledistilledwater.
StABIlityandStorage:12monthsfromdateofreceipt,-20oCto-70oC,assupplied.
1month,2oCto8oC,understerileconditionsafterreconstitution.
3months,-20oCto-70oC,understerileconditionsafterreconstitution.
Forinvitroinvestigationaluseonly.Notforuseindiagnosticortherapeuticprocedures.